Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells:: improvement following anti-tumor necrosis factor-α antibody therapy

被引:210
作者
Papadaki, HA
Kritikos, HD
Valatas, V
Boumpas, DT
Eliopoulos, GD
机构
[1] Univ Crete, Sch Med, Dept Hematol & Rheumatol, Iraklion, Greece
[2] Univ Crete, Sch Med, Dept Clin Immunol & Allergiol, Iraklion, Greece
关键词
D O I
10.1182/blood-2002-01-0136
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Circumstantial evidence has implicated tumor necrosis factor a (TNF-alpha) in the pathogenesis of anemia of chronic disease (ACD) in rheumatoid arthritis (RA). We investigated the role of TNF-alpha in erythropoiesis of patients with active RA (n = 40) and the effect of anti-TNF-alpha antibody administration (cA2). Patients with RA had lower numbers of CD34(+)/CD71(+) and CD36(-)/glycophorin A(+) (glycoA(+)) bone marrow (BM) cells and increased proportions of apoptotic cells within the CD34(+)/CD71(+) and CD36(+)/glycoA(+) cell compartments, compared to healthy controls (n = 24). Erythroid burst-forming units (BFU-Es) obtained by BM mononuclear or purified CD34(+) cells were significantly lower in RA patients compared to controls. These abnormalities were more pronounced among patients with ACD. Increased TNF-alpha levels in patient long-term BM culture supernatants inversely correlated with BFU-Es and hemoglobin levels and positively with the percentage of apoptotic CD34(+)/CD71(+) and CD36(+)/glycoA(+) cells. Following cA2 therapy, a normalization was documented in the number of CD34(+)/CD71(+) and CD36(-)/glycoA(+) cells, the number of BFU-Es, and the proportion of apoptotic CD34+/CD71+ and CD36+/glycoA+ cells, which was associated with a significant increase in hemoglobin levels compared to baseline. Recovery from anemia was more prominent In patients with ACID. The exogenous addition of an anti-TNF-alpha. antibody In the cultures Increased BFU-E number In patients prior to cA2 treatment but not after treatment, further substantiating the Inhibitory role of TNF-alpha on patients' erythropoiesis. We conclude that TNIF-alpha-mediated apoptotic depletion of BM erythroid cells may account for ACD in RA and that cA2 administration may ameliorate ACD In these patients by down-regulating the apoptotic mechanisms involved in erythropoiesis.
引用
收藏
页码:474 / 482
页数:9
相关论文
共 50 条
[1]  
ALVAREZHERNANDEZ X, 1989, LAB INVEST, V61, P319
[2]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[3]   INTERLEUKIN-6-ASSOCIATED ANEMIA - DETERMINATION OF THE UNDERLYING MECHANISM [J].
ATKINS, MB ;
KAPPLER, K ;
MIER, JW ;
ISAACS, RE ;
BERKMAN, EM .
BLOOD, 1995, 86 (04) :1288-1291
[4]   THE PATHOGENESIS OF ANEMIA IN RHEUMATOID-ARTHRITIS - A CLINICAL AND LABORATORY ANALYSIS [J].
BAER, AN ;
DESSYPRIS, EN ;
KRANTZ, SB .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1990, 19 (04) :209-223
[5]   INADEQUATE ERYTHROPOIETIN RESPONSE TO ANEMIA - DEFINITION AND CLINICAL RELEVANCE [J].
BAROSI, G .
ANNALS OF HEMATOLOGY, 1994, 68 (05) :215-223
[6]   INTERLEUKIN-6 IS REQUIRED IN-VIVO FOR THE REGULATION OF STEM-CELLS AND COMMITTED PROGENITORS OF THE HEMATOPOIETIC SYSTEM [J].
BERNAD, A ;
KOPF, M ;
KULBACKI, R ;
WEICH, N ;
KOEHLER, G ;
GUTIERREZRAMOS, JC .
IMMUNITY, 1994, 1 (09) :725-731
[7]   SERUM ERYTHROPOIETIN IN RHEUMATOID-ARTHRITIS AND OTHER INFLAMMATORY ARTHRITIDES - RELATIONSHIP TO ANEMIA AND THE EFFECT OF ANTIINFLAMMATORY TREATMENT [J].
BIRGEGARD, G ;
HALLGREN, R ;
CARO, J .
BRITISH JOURNAL OF HAEMATOLOGY, 1987, 65 (04) :479-483
[8]   The hematological effects of folate analogs: Implications for using the dihydrofolate reductase gene for in vivo selection [J].
Blau, CA ;
Neff, T ;
Papayannopoulou, T .
HUMAN GENE THERAPY, 1996, 7 (17) :2069-2078
[9]   Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis [J].
Cazzola, M ;
Ponchio, L ;
deBenedetti, F ;
Ravelli, A ;
Rosti, V ;
Beguin, Y ;
Invernizzi, R ;
Barosi, G ;
Martini, A .
BLOOD, 1996, 87 (11) :4824-4830
[10]  
CHARBORD P, 1995, HEMATOPOIETIC STEM C, P151